Q: Last week, Resverlogix received a positive confirmation from the FDA that it would likely support approval of BETon MACE based on the result of its Phase 3 study. The stock moved up ~28% today. It shows great promise in treating types of cardiovascular disease. From your experience, is it normal for the FDA to offer a positive comment? Would you have an opinion based on the FDA comment to open a position? I am a prudent investor yet have room for higher risk opportunities.
Thank you
Q: Hi guys I held these 2 companies for along while and both seem to be in a state of suspended animation .and I have been slightly underwater on both.
The div is good and grew on both but the cap loss is bothersome and the lack of interest by the market is constant.
Would you move on and look for more growth opportunities
Kind regards
Stan
Q: It's getting a little scary to see such huge profits in my portfolio (Cash, TFSA, RRIF). I know you are flexible about percentages, so I'd like your opinion on whether to reduce the following equities and by how much?
SIS 7% ; BABA 6% ; NVDA 9%; SHOP 8% ; ALGN 6% ; DOL 9% ; PBH 9%.
Many thanks for all your thoughtful advice.
Q: Is there any downside to buying ZWE for very long-term income purposes, i.e., would you anticipate a nasty price drop to this particular ETF?. Thank you.
If one were buying NFI and TSGI today - would you add equal weight into both positions, or would you be adding a larger position to TSGI over NFI? In other words, if the combined weighting was 7% between the 2 names, would you do 3.5 in each, 4/3, etc? My investing goal would be to achieve higher growth but still maintain diversification between the two holdings.
Q: Strikes me mgt placed own interests above those of shareholders in violation of fiduciary obligation. Your thoughts please? How does an invester protect themself from this practice, especially in the small Canadian market?
Q: Hi 5i,
The Baytex/Raging River transaction reminds me a little of the attempted merger of Dennison Mining and Fission Uranium, although there are some obvious differences too. In the latter, the FCU shareholders stepped up, voted against the merger, and the deal died, despite Fission management’s apparently supporting it. How likely is a similar scenario to play out with RRX? It may not always work this way but one might have thought that, if the proposed deal is so terrible for RRX shareholders, then it is really good for BTE shareholders. Yet BTE’s share price actually dropped more percentagewise than RRX’s did on the day. Were BTE shareholders really that enamored of the leverage that comes with a lousy balance sheet, and quarter after quarter of losses, that they didn’t want to accept the burden of higher quality, profitable assets? Finally, is it possible that this bad deal for good assets is being presented in order to force the hands of other potential buyers? And, in any event, how likely is someone else to look at it and say: Well, we can do better than that and still have it be accretive on an earnings and cash flow per share basis. (?) Thanks!
Q: Follow balanced equity portfolio and rebalancing. I do not have the 6 companies above. Please rank them in the order I should add. Any I should wait on to purchase for a price adjustment?
T as always Steve
Q: Hi. Starting from the end of May, Whitecap has dropped substantially (-17%) from its high. Is there a reason for this declline? Do you think it's the right time to step in? Please comment. Thanks always
I have a 3% position in Telus and a 5% position in Stella Jones and 5% in cash. I am looking to sell my positions in both. Can you suggest sector equivalents to those stocks, or do you recommend staying in those positions?